The effect of a targeted intensive intervention on cardiovascular risk factors (CRFs) and coronary risk (CR) in patients with type 2 diabetes (T2DM)

被引：0
|
作者：
del Cañizo, FJ [1 ]
Moreira, MN [1 ]
机构：
[1] Hosp Virgen Torre, Endocrinol Unit, Madrid, Spain
来源：
PROCEEDINGS OF THE 12TH INTERNATIONAL CONGRESS OF ENDOCRINOLOGY | 2004年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
To assess the effect of a targeted intensive intervention on CRFs and CR, in 406 T2DM subjects, blood pressure, HbA(1c), and lipids were measured, and CR predicted before and after 6 months of pharmacologic therapy implementation. After intervention there was a decrease in the mean of all CRFs and CR, and an increase in the percent of patients who reached the targets. This intervention on CRFs in T2DM patients had a beneficial effect over predicted CR.
引用
收藏
页码：591 / 593
页数：3
相关论文
共 50 条
  • [1] Motivational and psychological factors associated with control of Type 2 diabetes mellitus (T2DM) and cardiac risk factors (CRFs).
    Chyun, DA
    Katten, DM
    Minicucci, DS
    Davey, JA
    Khuwatsamrit, K
    Inzucchi, SE
    Melkus, GD
    [J]. DIABETOLOGIA, 2003, 46 : A425 - A425
  • [2] The effect of a targeted intensive pharmacologic intervention on modifiable cardiovascular risk factors and coronary risk in patients with type 2 diabetes mellitus without clinical coronary artery disease
    Moreira-Andres, MN
    Cañizo-Gómez, FJ
    [J]. DIABETOLOGIA, 2005, 48 : A263 - A263
  • [3] Cardiovascular risk factors in Mexican-American children at risk for type 2 diabetes mellitus (T2DM)
    Urrutia-Rojas, X
    Menchaca, J
    Wadley, W
    Ahmad, N
    Lacko, A
    Bae, S
    Spellman, C
    Kudchodkar, B
    Kudolo, G
    McConathy, W
    [J]. JOURNAL OF ADOLESCENT HEALTH, 2004, 34 (04) : 290 - 299
  • [4] Motivational factors and control of type 2 diabetes (T2DM) and coronary heart disease (CHD) risk factors
    Chyun, D
    Minicucci, D
    Katten, D
    Davey, J
    Grey, N
    Melkus, G
    [J]. GERONTOLOGIST, 2002, 42 : 216 - 217
  • [5] Risk of cardiovascular disease in patients with T2DM
    [J]. Nature Reviews Endocrinology, 2013, 9 (6) : 316 - 316
  • [6] Cardiovascular safety of dapagliflozin in type 2 diabetes mellitus (T2DM) patients with various degrees of cardiovascular risk
    Sonesson, C.
    Frederich, R.
    Johansson, P. A.
    Gause-Nilsson, I.
    Langkilde, A. M.
    List, J. F.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 : 1072 - 1072
  • [7] Dapagliflozin improves cardiovascular risk factors in Emirati patients with T2DM
    Nada, Aml Mohamed
    Younan, Mariam Adel
    [J]. THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2021, 12
  • [8] Use of electronic medical record to assess prevalence and treatment of cardiovascular risk factors in patients with type 2 diabetes (T2DM)
    Dushay, J
    Principe, A
    Beebe, G
    Kimker, L
    Abrahamson, MJ
    [J]. DIABETES, 2005, 54 : A607 - A607
  • [9] Adverse cardiovascular risk factors compared to glycemic control in type 2 diabetes (T2DM) patients without clinically evident coronary artery disease (CAD)
    Inzucchi, SE
    Chyun, DA
    Young, LH
    Davey, JA
    Wackers, FJT
    [J]. DIABETES, 2002, 51 : A8 - A8
  • [10] Risk Factors for Combined Severe Diabetic Complications (CSDC) in Patients with Type 2 Diabetes Mellitus (T2DM)
    Nanako, Tanaka
    Fujihara, Kazuya
    Yaguchi, Yuta
    Yamada, Mayuko H.
    Yamamoto, Masahiko
    Kitazawa, Masaru
    Matsubayashi, Yasuhiro
    Yamada, Takaho
    Kodama, Satoru
    Sone, Hirohito
    [J]. DIABETES, 2024, 73
12345